why choose us

Clinical Trials Search

Showing 14,560 of 132,963 result(s)
Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)

Status: Completed

Condition: Biliary Tract Cancer

Interventions: Participants will receive 1500 mg every 3 weeks, or every 4 weeks (in combination with chemotherapy every 3 weeks, or every 2 weeks, respectively) fro

Date: 2023-03-06

Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

Status: Completed

Condition: Colonic Neoplasms

Interventions: Moderate- to vigorous-intensity aerobic exercise

Date: 2023-03-06

The Effect of Incontinence Program Applied to Obese Elderly on Quality of Life, Coping and Loneliness

Status: NOT_YET_RECRUITING

Condition: Obesity, Primary

Interventions: Face-to-face training will be given to the elderly in the experimental group for a total of 5 weeks, once a week day (60 minutes).
In the 4th wee

Date: 2023-03-06

Perform® Humeral System - Fracture Study (PFX)

Status: Completed

Condition: Traumatic Arthropathy of Shoulder

Interventions:

A replacement of shoulder joints for anatomic and reverse shoulder arthroplasty.

A replacement of other shoulder joints devices in case of re

Date: 2023-03-06

Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)

Status: Completed

Condition: Hypercortisolism

Interventions: Mifepristone tablets for once daily oral dosing

Date: 2023-03-06

Virtual Reality in the Rehabilitation in Patients With Lower Limb Amputation.

Status: Completed

Condition: Amputation

Interventions: All patients will receive VR-assisted rehabilitation.
The VR-assisted rehabilitation is proceed with SyncVR® (Padualaan, Netherlands ) equipment,

Date: 2023-03-06

Serratus Anterior Plane Block Versus Pericapsular Nerve Group Block for Shoulder Surgery

Status: Completed

Condition: Shoulder Surgery

Interventions: The latissimus dorsi muscle between the midaxillary line and the posterior axillary line will be located under ultrasound guidance.
The needle wi

Date: 2023-03-06

Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

Status: NOT_YET_RECRUITING

Condition: Renal Pelvis and Ureter Urothelial Carcinoma

Interventions: Undergo tissue biopsy

Date: 2023-03-06

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

Status: Completed

Condition: High Grade Glioma

Interventions: TORISEL® (temsirolimus) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma.

Date: 2023-03-06

Harm Reduction Services

Status: NOT_YET_RECRUITING

Condition: Drug Use

Interventions: 8-week program targeting areas rooted in the 8 principles of harm reduction.
Includes weekly education lessons and informed referrals to social s

Date: 2023-03-06